key: cord-1004583-8tddp3ky
authors: Breen, H. J.
title: Help is at hand
date: 2021-02-12
journal: Br Dent J
DOI: 10.1038/s41415-021-2672-1
sha: e5be1d8bee8036821fca31cd0bf36ecb9dfbce19
doc_id: 1004583
cord_uid: 8tddp3ky

nan

hospital, and the infection protection control measures the authors acknowledge are carried out and therefore do not need to be part of the consent to the procedure itself.

'Montgomery' dealt specifically with the material risks of a medical procedure. The consent process is not invalidated by adding a line about the material risks of visiting a hospital, but neither does it augment the validity of that consent. The aim of an effective consent process is not to overwhelm the patient with so much information that they are left unable to process it all.

General dental practitioners who follow the SOP when providing dental treatment should continue to follow the BDA advice on consent 4 without adding any additional warnings about their surgeries. Dental surgeries that are non-compliant with the current SOP in their jurisdiction should not treat patients.

L. D'Cruz, Head of BDA Indemnity, London, UK

Sir, a recent letter about consent and the need to warn about a risk of catching COVID-19 while attending for dental treatment 1 is an interpretation of the Montgomery ruling, 2 which potentially undermines the current standard operating procedure (SOP) 3 and duplicates the warnings currently issued before attending a hospital appointment. It helps to distinguish between the procedure and the environment in which it is provided. COVID-19 is not a material risk of the dental procedure itself and prospective patients will already have been alerted to the risk of visiting the hospital setting. The risk from being in a hospital building will have been covered by the general advice/ instructions for anyone attending the

Sir, I was pleased to read the item ' Addiction and alcoholism in dentistry' . 1 In these COVID-19-dominated times, many of our colleagues are turning to drugs, alcohol and other behaviours to combat their workrelated anxieties and stresses. In many cases, this can lead to dependency and addiction, which can ultimately lead to their COMMENT Letters to the editor Send your letters to the Editor, British Dental Journal, 64 Wimpole Street, London, W1G 8YS. Email bdj@bda.org. Priority will be given to letters less than 500 words long. Authors must sign the letter, which may be edited for reasons of space. 

Sir, I have found an increase in patients disclosing to me how COVID-19 has affected their lives, hearing many harrowing tales of loss of husbands, jobs and houses. Further to this, an article recently published in the BMJ reported the potential increase of suicide rates from 1% to 145%, due to the surrounding effects of COVID-19. 1 As a newly qualified dentist in foundation training, I felt that not enough emphasis has been put on suicide prevention. As dental professionals, we need to be acutely aware of early warning signs and risks of suicide. As we create a rapport with our patients and see some patients regularly, it may be easier for us to note changes in patterns of behaviour. Now more than ever, this knowledge on suicide prevention could be invaluable to us and our communities.

Due to the unique current circumstances, we may be the only source of human interaction that some patients have, possibly being the only medical professionals they have seen face-toface for some time. I suggest that all dentists during this time should undertake additional CPD on suicide prevention. Knowing what signs to look for and how to manage the situation effectively will better equip us to protect our patients' mental and physical wellbeing. Understanding suicide and its risk factors could potentially save a life.

A. Osman, London, UK 

Sir, I am delighted to see the launch of the white paper, The essential role of the dental team in reducing antibiotic resistance, by the FDI World Dental Federation during the World Antimicrobial Awareness Week in November 2020. This white paper is supported by an online library of resources and accompanied by a massive open online course. 1 Concurrently, the Belgian Health Care Knowledge Centre also published Guideline on the prudent prescription of antibiotics in the dental office. This clinical practice guideline provides evidence-based recommendations for the prudent use of antibiotics in 12 situations frequently encountered in the dental surgery. The main objective of this guideline is to reduce the non-prudent prescription of antibiotics by dentists (and to a lesser extent by general practitioners) and ultimately to reduce antibacterial resistance. Another objective of this guideline is to reduce the variability in clinical practice and to improve the communication between care providers and patients (eg to explain why antibiotics are not indicated in certain situations). 2 In 2019, amoxicillin and phenoxymethylpenicillin (penicillin V) accounted for 68% and 0.4% of antibiotics prescribed in primary dental care, respectively, in Scotland. 3 Penicillin V has a narrower spectrum of antimicrobial activity than amoxicillin, but has equivalent efficacy and clinical outcomes in acute dento-alveolar infections. Limiting unintended consequences of antimicrobial use is a key principle of antimicrobial stewardship, and since amoxicillin has a broader spectrum of activity than penicillin V, it has a greater impact on selection of resistance in the host micro-flora. Following an extensive period of research and consultation, the Scottish Antimicrobial Prescribing Group and its dental subgroup have

Sir, many dental core trainees have moved away from friends and family and often live on their own or with new people. I wonder whether deaneries should bear some responsibility for making sure that their trainees are coping and signposting them towards any help that is available. The deaneries are fully aware of the national recruitment element of jobs and that

Sir, I wish to report on the experience of the routine use of 0.5% povidone iodine (PVP-I) mouthwashes and nasal sprays in 6,000 consecutive dental patients, all of whom were notified of the need to use a mouthwash and nasal spray before dental treatment and of possible exclusions on the grounds of a history of allergy to iodine. Three patients were excluded.

The mouthwash was taken in the prescribed manner; held and moved round the mouth for 60 seconds and spat out into a plastic beaker. All patients consented to use of the mouthwash. There were no complaints of taste or procedure and no reports of any adverse reactions. All staff felt more relaxed about providing dental treatment with patients using such an effective antiviral mouthwash. We understand that research is being undertaken to determine the duration of the virucidal activity in the mouth, with preliminary indications that this might be up to two hours. If safety rather than effectiveness is the reason that august UK bodies have not yet enthusiastically endorsed the use of pre-operative mouthwashes, we hope that information from practice may help.

P. Davis, Tavistock, UK https://doi.org/10.1038/s41415-021-2674-z  

Oral manifestations associated with COVID-19

Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?

Immunologic and psychologic parameters associated with geographic tongue. Oral Surg Oral Med Oral Pathol Oral Radiol

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Informed consent

Standard Operating Procedure: Transition to recovery v4

BDA advice: Consent